ABM was acquired by Cadence Health Capital last month. A new leadership team at the neurology-forward sleep company plans to streamline operations and expand the clinical reach of validated technologies for sleep apnea, insomnia, and neurodegenerative disease. By Sree Roy On May 20, Advanced Brain Monitoring (ABM), a company known within the sleep medicine community for its research-heavy approach to EEG and home sleep testing, was acquired by C…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.